TY - JOUR
T1 - Cold activation of serum complement in patients with chronic hepatitis C
T2 - Study on activating pathway and involvement of IgG
AU - Ishii, Yasushi
AU - Shimomura, Hiroyuki
AU - Itoh, Mamoru
AU - Miyake, Masanobu
AU - Ikeda, Fusao
AU - Miyaike, Jiro
AU - Fujioka, Shin Ichi
AU - Iwasaki, Yoshiaki
AU - Tsuji, Hideyuki
AU - Tsuji, Takao
PY - 2001/12/1
Y1 - 2001/12/1
N2 - It has been documented that the serum complement activities measured by hemolytic assay (CH50) are decreased after storage of sera at a low temperature in some patients with chronic hepatitis C. However, the mechanism of this phenomenon has not been identified yet. Here, we tried to elucidate factors involved in the cold activation of complement (CAC). To clarify what pathway is activated in CAC, we measured complement cleavage products after cold storage of sera. C4d increased significantly after 12 h-storage at cold temperatures in 5 CAC (+) sera compared with 5 CAC (-) (P < 0.01) and 3 control sera (P < 0.05), while Bb did not increase in any of the groups. In order to determine whether IgG or IgG complex is necessary for CAC, 8 CAC (+) sera were incubated with Protein G Sepharose gel beads, and all of them retained hemolytic activities to some extent after cold storage. Column chromatography through Superose 6HR of CAC-positive serum identified the fractions containing molecules that induced CAC in normal serum, which were depleted by treatment with protein G Sepharose. In conclusion, CAC in hepatitis C seems to occur via a classical or lectin pathway, and the IgG complex produced in hepatitis C virus infection may be an important factor in inducing CAC, a common extrahepatic manifestation of hepatitis C.
AB - It has been documented that the serum complement activities measured by hemolytic assay (CH50) are decreased after storage of sera at a low temperature in some patients with chronic hepatitis C. However, the mechanism of this phenomenon has not been identified yet. Here, we tried to elucidate factors involved in the cold activation of complement (CAC). To clarify what pathway is activated in CAC, we measured complement cleavage products after cold storage of sera. C4d increased significantly after 12 h-storage at cold temperatures in 5 CAC (+) sera compared with 5 CAC (-) (P < 0.01) and 3 control sera (P < 0.05), while Bb did not increase in any of the groups. In order to determine whether IgG or IgG complex is necessary for CAC, 8 CAC (+) sera were incubated with Protein G Sepharose gel beads, and all of them retained hemolytic activities to some extent after cold storage. Column chromatography through Superose 6HR of CAC-positive serum identified the fractions containing molecules that induced CAC in normal serum, which were depleted by treatment with protein G Sepharose. In conclusion, CAC in hepatitis C seems to occur via a classical or lectin pathway, and the IgG complex produced in hepatitis C virus infection may be an important factor in inducing CAC, a common extrahepatic manifestation of hepatitis C.
KW - Chronic hepatitis
KW - Complement activation
KW - Hepatitis C virus
UR - http://www.scopus.com/inward/record.url?scp=0035432441&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035432441&partnerID=8YFLogxK
M3 - Article
C2 - 11512565
AN - SCOPUS:0035432441
SN - 0386-300X
VL - 55
SP - 229
EP - 235
JO - Acta Medica Okayama
JF - Acta Medica Okayama
IS - 4
ER -